These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 7561063
1. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. Cavacini LA, Emes CL, Power J, Desharnais FD, Duval M, Montefiori D, Posner MR. J Immunol; 1995 Oct 01; 155(7):3638-44. PubMed ID: 7561063 [Abstract] [Full Text] [Related]
3. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. Posner MR, Hideshima T, Cannon T, Mukherjee M, Mayer KH, Byrn RA. J Immunol; 1991 Jun 15; 146(12):4325-32. PubMed ID: 1710248 [Abstract] [Full Text] [Related]
4. Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals. Cavacini LA, Kuhrt D, Duval M, Mayer K, Posner MR. AIDS Res Hum Retroviruses; 2003 Sep 15; 19(9):785-92. PubMed ID: 14585209 [Abstract] [Full Text] [Related]
5. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C. Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249 [Abstract] [Full Text] [Related]
6. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. Liu F, Bergami PL, Duval M, Kuhrt D, Posner M, Cavacini L. AIDS Res Hum Retroviruses; 2003 Jul 17; 19(7):597-607. PubMed ID: 12908937 [Abstract] [Full Text] [Related]
7. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. Posner MR, Cavacini LA, Emes CL, Power J, Byrn R. J Acquir Immune Defic Syndr (1988); 1993 Jan 17; 6(1):7-14. PubMed ID: 8417177 [Abstract] [Full Text] [Related]
8. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event. McInerney TL, McLain L, Armstrong SJ, Dimmock NJ. Virology; 1997 Jul 07; 233(2):313-26. PubMed ID: 9217055 [Abstract] [Full Text] [Related]
9. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120. Kang CY, Hariharan K, Posner MR, Nara P. J Immunol; 1993 Jul 01; 151(1):449-57. PubMed ID: 7686944 [Abstract] [Full Text] [Related]
10. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells. Clayton R, Ohagen A, Goethals O, Smets A, Van Loock M, Michiels L, Kennedy-Johnston E, Cunningham M, Jiang H, Bola S, Gutshall L, Gunn G, Del Vecchio A, Sarisky R, Hallenberger S, Hertogs K. J Virol Methods; 2007 Jan 01; 139(1):17-23. PubMed ID: 17034868 [Abstract] [Full Text] [Related]
11. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1. Meyuhas R, Noy H, Montefiori DC, Denisova G, Gershoni JM, Gross G. Mol Immunol; 2005 May 01; 42(9):1099-109. PubMed ID: 15829299 [Abstract] [Full Text] [Related]
12. Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. Cavacini LA, Samore MH, Gambertoglio J, Jackson B, Duval M, Wisnewski A, Hammer S, Koziel C, Trapnell C, Posner MR. AIDS Res Hum Retroviruses; 1998 May 01; 14(7):545-50. PubMed ID: 9591708 [Abstract] [Full Text] [Related]
14. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site. Klasse PJ, McKeating JA, Schutten M, Reitz MS, Robert-Guroff M. Virology; 1993 Sep 01; 196(1):332-7. PubMed ID: 8356803 [Abstract] [Full Text] [Related]
15. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. Zhang YJ, Fredriksson R, McKeating JA, Fenyö EM. Virology; 1997 Nov 24; 238(2):254-64. PubMed ID: 9400598 [Abstract] [Full Text] [Related]
16. Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5. Ou W, Lu N, Yu SS, Silver J. J Virol; 2006 Mar 24; 80(5):2539-47. PubMed ID: 16474160 [Abstract] [Full Text] [Related]
17. Human monoclonal antibodies to the V3 loop of HIV-1 gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding site. Cavacini LA, Emes CL, Power J, Buchbinder A, Zolla-Pazner S, Posner MR. J Acquir Immune Defic Syndr (1988); 1993 Apr 24; 6(4):353-8. PubMed ID: 8455141 [Abstract] [Full Text] [Related]
18. Construction of reshaped human antibodies with HIV-neutralizing activity. Maeda H, Matsushita S, Eda Y, Kimachi K, Tokiyoshi S, Bendig MM. Hum Antibodies Hybridomas; 1991 Jul 24; 2(3):124-34. PubMed ID: 1873503 [Abstract] [Full Text] [Related]
19. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Bagley J, Dillon PJ, Rosen C, Robinson J, Sodroski J, Marasco WA. Mol Immunol; 1994 Oct 24; 31(15):1149-60. PubMed ID: 7935503 [Abstract] [Full Text] [Related]
20. Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. Scharf O, Golding H, King LR, Eller N, Frazier D, Golding B, Scott DE. J Virol; 2001 Jul 24; 75(14):6558-65. PubMed ID: 11413323 [Abstract] [Full Text] [Related] Page: [Next] [New Search]